Alto Neuroscience, Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Alto Neuroscience, Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Net Income — By Quarter
| Quarter | Fiscal Year | Period End | Value | Filed |
|---|---|---|---|---|
| Q3 | 2025 | Sep 30, 2025 | ($14.18M) | Nov 12, 2025 |
| Q3 | 2025 | Jun 30, 2025 | ($17.71M) | Nov 12, 2025 |
| Q2 | 2025 | Jun 30, 2025 | ($17.71M) | Aug 13, 2025 |
| Q3 | 2025 | Mar 31, 2025 | ($15.17M) | Nov 12, 2025 |
| Q2 | 2025 | Mar 31, 2025 | ($15.17M) | Aug 13, 2025 |
| Q1 | 2025 | Mar 31, 2025 | ($15.17M) | May 14, 2025 |
| Q3 | 2025 | Sep 30, 2024 | ($16.78M) | Nov 12, 2025 |
| Q2 | 2025 | Jun 30, 2024 | ($16.03M) | Aug 13, 2025 |
| Q3 | 2025 | Jun 30, 2024 | ($16.03M) | Nov 12, 2025 |
| Q1 | 2025 | Mar 31, 2024 | ($13.42M) | May 14, 2025 |
| Q3 | 2025 | Mar 31, 2024 | ($13.42M) | Nov 12, 2025 |
| Q2 | 2025 | Mar 31, 2024 | ($13.42M) | Aug 13, 2025 |
| Q3 | 2024 | Sep 30, 2023 | ($9.14M) | Nov 12, 2024 |
| Q2 | 2024 | Jun 30, 2023 | ($8.66M) | Aug 13, 2024 |
| Q3 | 2024 | Jun 30, 2023 | ($8.66M) | Nov 12, 2024 |
| Q2 | 2024 | Mar 31, 2023 | ($7.28M) | Aug 13, 2024 |
| Q1 | 2024 | Mar 31, 2023 | ($7.28M) | May 14, 2024 |
| Q3 | 2024 | Mar 31, 2023 | ($7.28M) | Nov 12, 2024 |
Operating Income — By Quarter
| Quarter | Fiscal Year | Period End | Value | Filed |
|---|---|---|---|---|
| Q3 | 2025 | Sep 30, 2025 | ($14.95M) | Nov 12, 2025 |
| Q2 | 2025 | Jun 30, 2025 | ($18.68M) | Aug 13, 2025 |
| Q1 | 2025 | Mar 31, 2025 | ($15.68M) | May 14, 2025 |
| Q3 | 2025 | Sep 30, 2024 | ($18.89M) | Nov 12, 2025 |
| Q2 | 2025 | Jun 30, 2024 | ($18.34M) | Aug 13, 2025 |
| Q1 | 2025 | Mar 31, 2024 | ($14.39M) | May 14, 2025 |
| Q3 | 2024 | Sep 30, 2023 | ($9.72M) | Nov 12, 2024 |
| Q2 | 2024 | Jun 30, 2023 | ($9.13M) | Aug 13, 2024 |
| Q1 | 2024 | Mar 31, 2023 | ($7.20M) | May 14, 2024 |